Skip to main content
PMC home page
RNA logoLink to RNA
. 2002 Mar;8(3):357–369. doi: 10.1017/s1355838202028194

Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS.

Nancy Beerens 1, Ben Berkhout 1
PMCID: PMC1370257  PMID: 12003495

Abstract

Reverse transcription of the HIV-1 RNA genome is primed by the cellular tRNA(lys3) molecule that anneals to a complementary sequence in the viral genome, the primer-binding site (PBS). Additional interactions between the tRNA primer and the viral RNA were proposed to play a role in reverse transcription. We recently identified an 8-nt element in the U5 region upstream of the PBS that is critical for initiation and processive elongation of reverse transcription. This motif was termed the primer activation signal (PAS), and is proposed to interact with the "antiPAS sequence" in the TphiC arm of tRNA(lys3). In this study, we demonstrate that the efficiency of initiation of reverse transcription can be modulated by PAS mutations that strengthen or weaken the interaction with antiPAS. These results provide further evidence for a direct base-pairing interaction between the PAS in the viral RNA and the antiPAS in the tRNA(lys3) molecule. A broad phylogenetic survey indicated that a PAS element is present in all retroviral RNA genomes, suggesting that the process of reverse transcription is regulated by a common mechanism in all retroviridae. It has proven very difficult to change the identity of the tRNA primer for HIV-1 reverse transcription by changing the PBS sequence. Using in vitro reverse transcription assays, we demonstrate that the identity of the priming tRNA species can be switched by simultaneous alteration of the PBS and PAS motifs to accommodate a new tRNA primer. These results indicate that the PAS-antiPAS interaction is important for both primer selection and efficient reverse transcription.

Full Text

The Full Text of this article is available as a PDF (12.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiyar A., Cobrinik D., Ge Z., Kung H. J., Leis J. Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol. 1992 Apr;66(4):2464–2472. doi: 10.1128/jvi.66.4.2464-2472.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aiyar A., Ge Z., Leis J. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol. 1994 Feb;68(2):611–618. doi: 10.1128/jvi.68.2.611-618.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arts E. J., Stetor S. R., Li X., Rausch J. W., Howard K. J., Ehresmann B., North T. W., Wöhrl B. M., Goody R. S., Wainberg M. A. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10063–10068. doi: 10.1073/pnas.93.19.10063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barat C., Le Grice S. F., Darlix J. L. Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3). Nucleic Acids Res. 1991 Feb 25;19(4):751–757. doi: 10.1093/nar/19.4.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barat C., Schatz O., Le Grice S., Darlix J. L. Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase. J Mol Biol. 1993 May 20;231(2):185–190. doi: 10.1006/jmbi.1993.1273. [DOI] [PubMed] [Google Scholar]
  6. Beerens N., Groot F., Berkhout B. Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem. 2001 May 30;276(33):31247–31256. doi: 10.1074/jbc.M102441200. [DOI] [PubMed] [Google Scholar]
  7. Beerens N., Groot F., Berkhout B. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription. Nucleic Acids Res. 2000 Nov 1;28(21):4130–4137. doi: 10.1093/nar/28.21.4130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beerens Nancy, Berkhout Ben. The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J Virol. 2002 Mar;76(5):2329–2339. doi: 10.1128/jvi.76.5.2329-2339.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Berkhout B., Schoneveld I. Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res. 1993 Mar 11;21(5):1171–1178. doi: 10.1093/nar/21.5.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown H. E., Chen H., Engelman A. Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis. J Virol. 1999 Nov;73(11):9011–9020. doi: 10.1128/jvi.73.11.9011-9020.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cobrinik D., Aiyar A., Ge Z., Katzman M., Huang H., Leis J. Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol. 1991 Jul;65(7):3864–3872. doi: 10.1128/jvi.65.7.3864-3872.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cobrinik D., Soskey L., Leis J. A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J Virol. 1988 Oct;62(10):3622–3630. doi: 10.1128/jvi.62.10.3622-3630.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Das A. T., Berkhout B. Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res. 1995 Apr 25;23(8):1319–1326. doi: 10.1093/nar/23.8.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Das A. T., Klaver B., Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol. 1995 May;69(5):3090–3097. doi: 10.1128/jvi.69.5.3090-3097.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. De Rocquigny H., Gabus C., Vincent A., Fournié-Zaluski M. C., Roques B., Darlix J. L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472–6476. doi: 10.1073/pnas.89.14.6472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Esposito D., Craigie R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 1998 Oct 1;17(19):5832–5843. doi: 10.1093/emboj/17.19.5832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Feng Y. X., Campbell S., Harvin D., Ehresmann B., Ehresmann C., Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol. 1999 May;73(5):4251–4256. doi: 10.1128/jvi.73.5.4251-4256.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Freund F., Boulmé F., Litvak S., Tarrago-Litvak L. Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex. Nucleic Acids Res. 2001 Jul 1;29(13):2757–2765. doi: 10.1093/nar/29.13.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fu W., Ortiz-Conde B. A., Gorelick R. J., Hughes S. H., Rein A. Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses. J Virol. 1997 Sep;71(9):6940–6946. doi: 10.1128/jvi.71.9.6940-6946.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Huang Y., Mak J., Cao Q., Li Z., Wainberg M. A., Kleiman L. Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1. J Virol. 1994 Dec;68(12):7676–7683. doi: 10.1128/jvi.68.12.7676-7683.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Isel C., Ehresmann C., Keith G., Ehresmann B., Marquet R. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J Mol Biol. 1995 Mar 24;247(2):236–250. doi: 10.1006/jmbi.1994.0136. [DOI] [PubMed] [Google Scholar]
  22. Isel C., Keith G., Ehresmann B., Ehresmann C., Marquet R. Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex. Nucleic Acids Res. 1998 Mar 1;26(5):1198–1204. doi: 10.1093/nar/26.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Isel C., Lanchy J. M., Le Grice S. F., Ehresmann C., Ehresmann B., Marquet R. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. EMBO J. 1996 Feb 15;15(4):917–924. [PMC free article] [PubMed] [Google Scholar]
  24. Isel C., Westhof E., Massire C., Le Grice S. F., Ehresmann B., Ehresmann C., Marquet R. Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J. 1999 Feb 15;18(4):1038–1048. doi: 10.1093/emboj/18.4.1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kang S. M., Wakefield J. K., Morrow C. D. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription. Virology. 1996 Aug 15;222(2):401–414. doi: 10.1006/viro.1996.0437. [DOI] [PubMed] [Google Scholar]
  26. Kang S. M., Zhang Z., Morrow C. D. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J Virol. 1997 Jan;71(1):207–217. doi: 10.1128/jvi.71.1.207-217.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lanchy J. M., Isel C., Keith G., Le Grice S. F., Ehresmann C., Ehresmann B., Marquet R. Dynamics of the HIV-1 reverse transcription complex during initiation of DNA synthesis. J Biol Chem. 2000 Apr 21;275(16):12306–12312. doi: 10.1074/jbc.275.16.12306. [DOI] [PubMed] [Google Scholar]
  28. Levin J. G., Seidman J. G. Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol. 1979 Jan;29(1):328–335. doi: 10.1128/jvi.29.1.328-335.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Li X., Mak J., Arts E. J., Gu Z., Kleiman L., Wainberg M. A., Parniak M. A. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol. 1994 Oct;68(10):6198–6206. doi: 10.1128/jvi.68.10.6198-6206.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Li Y., Zhang Z., Wakefield J. K., Kang S. M., Morrow C. D. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His). J Virol. 1997 Sep;71(9):6315–6322. doi: 10.1128/jvi.71.9.6315-6322.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Liang C., Li X., Rong L., Inouye P., Quan Y., Kleiman L., Wainberg M. A. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J Virol. 1997 Aug;71(8):5750–5757. doi: 10.1128/jvi.71.8.5750-5757.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Liang C., Rong L., Götte M., Li X., Quan Y., Kleiman L., Wainberg M. A. Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription. J Biol Chem. 1998 Aug 14;273(33):21309–21315. doi: 10.1074/jbc.273.33.21309. [DOI] [PubMed] [Google Scholar]
  33. Liang C., Rong L., Morin N., Cherry E., Huang Y., Kleiman L., Wainberg M. A. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. J Virol. 1997 Dec;71(12):9075–9086. doi: 10.1128/jvi.71.12.9075-9086.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mak J., Jiang M., Wainberg M. A., Hammarskjöld M. L., Rekosh D., Kleiman L. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J Virol. 1994 Apr;68(4):2065–2072. doi: 10.1128/jvi.68.4.2065-2072.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mak J., Kleiman L. Primer tRNAs for reverse transcription. J Virol. 1997 Nov;71(11):8087–8095. doi: 10.1128/jvi.71.11.8087-8095.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mathews D. H., Sabina J., Zuker M., Turner D. H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol. 1999 May 21;288(5):911–940. doi: 10.1006/jmbi.1999.2700. [DOI] [PubMed] [Google Scholar]
  37. Miller J. T., Ehresmann B., Hübscher U., Le Grice S. F. A novel interaction of tRNA(Lys,3) with the feline immunodeficiency virus RNA genome governs initiation of minus strand DNA synthesis. J Biol Chem. 2001 May 15;276(29):27721–27730. doi: 10.1074/jbc.M100513200. [DOI] [PubMed] [Google Scholar]
  38. Miller J. T., Ge Z., Morris S., Das K., Leis J. Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop. J Virol. 1997 Oct;71(10):7648–7656. doi: 10.1128/jvi.71.10.7648-7656.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Morris S., Leis J. Changes in Rous sarcoma virus RNA secondary structure near the primer binding site upon tRNATrp primer annealing. J Virol. 1999 Aug;73(8):6307–6318. doi: 10.1128/jvi.73.8.6307-6318.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Murphy J. E., Goff S. P. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J Virol. 1989 Jan;63(1):319–327. doi: 10.1128/jvi.63.1.319-327.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Oude Essink B. B., Das A. T., Berkhout B. HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol. 1996 Nov 29;264(2):243–254. doi: 10.1006/jmbi.1996.0638. [DOI] [PubMed] [Google Scholar]
  42. Oude Essink B. B., Das A. T., Berkhout B. Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. J Biol Chem. 1995 Oct 6;270(40):23867–23874. doi: 10.1074/jbc.270.40.23867. [DOI] [PubMed] [Google Scholar]
  43. Peters G. G., Hu J. Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles. J Virol. 1980 Dec;36(3):692–700. doi: 10.1128/jvi.36.3.692-700.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Peters G., Harada F., Dahlberg J. E., Panet A., Haseltine W. A., Baltimore D. Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol. 1977 Mar;21(3):1031–1041. doi: 10.1128/jvi.21.3.1031-1041.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rein A., Henderson L. E., Levin J. G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem Sci. 1998 Aug;23(8):297–301. doi: 10.1016/s0968-0004(98)01256-0. [DOI] [PubMed] [Google Scholar]
  46. Sawyer R. C., Hanafusa H. Comparison of the small RNAs of polymerase-deficient and polymerase-positive Rous sarcoma virus and another species of avian retrovirus. J Virol. 1979 Mar;29(3):863–871. doi: 10.1128/jvi.29.3.863-871.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sprinzl M., Hartmann T., Weber J., Blank J., Zeidler R. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res. 1989;17 (Suppl):r1–172. doi: 10.1093/nar/17.suppl.r1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Vicenzi E., Dimitrov D. S., Engelman A., Migone T. S., Purcell D. F., Leonard J., Englund G., Martin M. A. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol. 1994 Dec;68(12):7879–7890. doi: 10.1128/jvi.68.12.7879-7890.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wakefield J. K., Kang S. M., Morrow C. D. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). J Virol. 1996 Feb;70(2):966–975. doi: 10.1128/jvi.70.2.966-975.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wakefield J. K., Rhim H., Morrow C. D. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J Virol. 1994 Mar;68(3):1605–1614. doi: 10.1128/jvi.68.3.1605-1614.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wakefield J. K., Wolf A. G., Morrow C. D. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys). J Virol. 1995 Oct;69(10):6021–6029. doi: 10.1128/jvi.69.10.6021-6029.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Waters L. C., Mullin B. C. Transfer RNA into RNA tumor viruses. Prog Nucleic Acid Res Mol Biol. 1977;20:131–160. doi: 10.1016/s0079-6603(08)60471-7. [DOI] [PubMed] [Google Scholar]
  53. Wöhrl B. M., Ehresmann B., Keith G., Le Grice S. F. Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes. J Biol Chem. 1993 Jun 25;268(18):13617–13624. [PubMed] [Google Scholar]
  54. Zhang Z., Kang S. M., Li Y., Morrow C. D. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription. RNA. 1998 Apr;4(4):394–406. [PMC free article] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES